ReviewTherapeutic advances in neurological disorders2015

The pharmacological profile and clinical prospects of the oral 5-HT1F receptor agonist lasmiditan in the acute treatment of migraine.

Uwe Reuter et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.